BioXcel Therapeutics, Inc. (BTAI) › Total AssetsBioXcel Therapeutics, Inc. (BTAI) — Total AssetsAnnual figures by fiscal year, from SEC filings.2017: $1.35M2018: $43.55M2019: $36.39M2020: $219.94M2021: $239.44M2022: $205.85M2023: $73.70M2024: $38.34M2025: $44.92M$44.92M2017Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$44.92M+17.2%2024$38.34M-48.0%2023$73.70M-64.2%2022$205.85M-14.0%2021$239.44M+8.9%2020$219.94M+504.4%2019$36.39M-16.4%2018$43.55M+3113.9%2017$1.35M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share